foxo4-dri senolytic peptide 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound ES2 rapidly destroys TP53-FOXO4 foci

It is widely available through skincare and hair care brands without the need for a prescription

The practice comes from observations that continuous peptide use may reduce effectiveness over time and that breaks allow receptor sensitivity to reset

Potential for stronger effect: Because the bioavailability (the fraction of the administered dose that reaches circulation) can be higher via injection, the impact on sleep architecture (e.g., slow-wave sleep increases) may be more pronounced

BPC-157 works in the body through proposed repair pathways that involve blood vessel growth, cell movement, inflammation control, and tissue-protective signaling, but most evidence comes from animal and laboratory studies rather than confirmed human trials